DOI QR코드

DOI QR Code

Evaluation of Appropriate Management of Chronic Obstructive Pulmonary Disease in Korea: Based on Health Insurance Review and Assessment Service (HIRA) Claims

  • Chung, Sang Mi (Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital) ;
  • Lee, Sung Yong (Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital)
  • 투고 : 2017.06.07
  • 심사 : 2017.06.12
  • 발행 : 2017.07.31

초록

Chronic obstructive pulmonary disease (COPD) is an ambulatory care-sensitive condition, and effective treatment of outpatients can prevent worsening of the illness and hospitalization. Current COPD guidelines provide appropriate guidance for the diagnosis and treatment of patients with COPD. In fact, it has been shown that when appropriate guidance and treatment are performed, the morbidity and mortality rates of COPD patients are reduced. However, there is a gap between the clinical guidelines and the actual clinical treatment. Therefore, the Health Insurance Review and Assessment Service (HIRA) conducted an evaluation of the adequacy of COPD diagnosis and treatment using the Claims Database of HIRA. This review provides a summary of the COPD adequacy assessment results reported by the HIRA and some brief comments on the results.

키워드

참고문헌

  1. Yoo KH, Kim YS, Sheen SS, Park JH, Hwang YI, Kim SH, et al. Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology 2011;16:659-65. https://doi.org/10.1111/j.1440-1843.2011.01951.x
  2. Lee J, Lee JH, Kim JA, Rhee CK. Trend of cost and utilization of COPD medication in Korea. Int J Chron Obstruct Pulmon Dis 2017;12:27-33.
  3. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442. https://doi.org/10.1371/journal.pmed.0030442
  4. Lee JY, Rhee CK, Jung KS, Yoo KH. Strategies for management of the early chronic obstructive lung disease. Tuberc Respir Dis 2016;79:121-6. https://doi.org/10.4046/trd.2016.79.3.121
  5. Organisation for Economic Co-operation and Development. Health at a glance 2015: OECD indicators. Paris: OECD; 2015.
  6. Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Eur Respir J 2017;49:1700214. https://doi.org/10.1183/13993003.00214-2017
  7. Health Insurance Review & Assessment Service. Evaluation of appropriate management of COPD in Korea 2017 [Internet]. Wonju: Health Insurance Review & Assessment Service; 2017 [cited 2017 May 1]. Available from: http://www.hira.or.kr/re/diag/getDiagEvlList.do?pgmid=HIRAA030004000000&WT. ac=%EB%B3%91%EC%9B%90%ED%8F%89%EA%B0%80.
  8. Beeh KM. The role of bronchodilators in preventing exacerbations of chronic obstructive pulmonary disease. Tuberc Respir Dis 2016;79:241-7. https://doi.org/10.4046/trd.2016.79.4.241

피인용 문헌

  1. Significant predictors of medically diagnosed chronic obstructive pulmonary disease in patients with preserved ratio impaired spirometry: a 3-year cohort study vol.19, pp.None, 2017, https://doi.org/10.1186/s12931-018-0896-7
  2. Direct and Indirect Costs of Chronic Obstructive Pulmonary Disease in Korea vol.82, pp.1, 2017, https://doi.org/10.4046/trd.2018.0035
  3. The effect of low body mass index on the development of chronic obstructive pulmonary disease and mortality vol.286, pp.5, 2019, https://doi.org/10.1111/joim.12949
  4. Reducing chronic obstructive pulmonary disease mortality in Korea: early diagnosis matters vol.34, pp.6, 2017, https://doi.org/10.3904/kjim.2019.327
  5. Frequent Outpatient Visits Prevent Exacerbation of Chronic Obstructive Pulmonary Disease vol.10, pp.None, 2017, https://doi.org/10.1038/s41598-020-63064-x
  6. Effectiveness of Nationwide COPD Pay-for-Performance Program on COPD Exacerbations in Taiwan vol.16, pp.None, 2021, https://doi.org/10.2147/copd.s329454
  7. Cut-off value of FEV1/FEV6 to determine airflow limitation using handheld spirometry in subjects with risk of chronic obstructive pulmonary disease vol.36, pp.3, 2017, https://doi.org/10.3904/kjim.2019.314
  8. The nationwide retrospective cohort study by Health Insurance Review and Assessment Service proves that asthma management decreases the exacerbation risk of asthma vol.11, pp.1, 2017, https://doi.org/10.1038/s41598-021-81022-z
  9. Low alanine aminotransferase as a risk factor for chronic obstructive pulmonary disease in males vol.11, pp.1, 2021, https://doi.org/10.1038/s41598-021-94385-0
  10. Influence of government-driven quality assessment program on patients with chronic obstructive pulmonary disease vol.22, pp.1, 2017, https://doi.org/10.1186/s12931-021-01684-1